The effect of 5′ and 3′ non-translated regions on the expression of a transgene from a Newcastle disease virus vector
•Cognate UTRs of NDV modulate the expression of transgene.•M UTRs strongly increase transgene expression in hela cells.•HN 5′UTR promotes efficient mRNA translation. Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. T...
Saved in:
Published in | Virus research Vol. 341; p. 199309 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.03.2024
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Cognate UTRs of NDV modulate the expression of transgene.•M UTRs strongly increase transgene expression in hela cells.•HN 5′UTR promotes efficient mRNA translation.
Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5′ and 3′ untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5′UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use. |
---|---|
AbstractList | Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5' and 3' untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5'UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use.Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5' and 3' untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5'UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use. Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5′ and 3′ untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5′UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use. • Cognate UTRs of NDV modulate the expression of transgene. • M UTRs strongly increase transgene expression in hela cells. • HN 5′UTR promotes efficient mRNA translation. Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5′ and 3′ untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5′UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use. •Cognate UTRs of NDV modulate the expression of transgene.•M UTRs strongly increase transgene expression in hela cells.•HN 5′UTR promotes efficient mRNA translation. Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5′ and 3′ untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5′UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use. |
ArticleNumber | 199309 |
Author | Samal, Siba K. Belov, George A. Viktorova, Ekaterina Chowdhury, Ishita Roy |
Author_xml | – sequence: 1 givenname: Ishita Roy surname: Chowdhury fullname: Chowdhury, Ishita Roy – sequence: 2 givenname: Ekaterina surname: Viktorova fullname: Viktorova, Ekaterina – sequence: 3 givenname: Siba K. surname: Samal fullname: Samal, Siba K. – sequence: 4 givenname: George A. orcidid: 0000-0002-0892-1731 surname: Belov fullname: Belov, George A. email: gbelov@umd.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38181903$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUstuEzEUtVARTQu_UHnJZoJf48cKUMWjUgWbsrY89p3U0WQc7EmgO76JT-JL8CRtRVesbF2fx_W95wydjGkEhC4oWVJC5Zv1ch_zrmQoS0aYWFJjODHP0IJqxRolDDtBiwrUDVWEnaKzUtaEEMmVfIFOuaaaGsIX6O7mFjD0PfgJpx63f379xm4MmM-X6tlM2Y1lcBMEnGEV01hwGvE0s35uq32ppZnp8AG5ghFwn9OmFr7AD-_KNAAOsYArgA894301S_klet67ocCr-_Mcffv44ebyc3P99dPV5fvrxgvdTo2WnFPOiBdMBllLgjDiJAETwNFO-6C41AyCYsE7zrves9ZQJokToTctP0dXR92Q3Npuc9y4fGeTi_ZQSHllXZ6iH8AeXLpWCUW1cKHVRvVaUtPJVimnuqr19qi13XUbCB7G-unhiejTlzHe2lXaW0rqxJlgVeH1vUJO33dQJruJxcMwuBHSrlhmqFFCtFpVqDxCfU6lbrp_9KHEziGwa_sQAjuHwB5DUIkX_3b5SHvYegW8OwKgzn0fIdviI4weQsx1N3Uw8X8efwGwE8sN |
Cites_doi | 10.1186/1297-9716-42-38 10.1016/j.coviro.2023.101348 10.1099/vir.0.068437-0 10.20506/rst.19.2.1231 10.3390/v12111249 10.1016/0092-8674(86)90762-2 10.1038/s41598-020-59124-x 10.1128/JVI.00976-18 10.1016/j.vaccine.2019.10.074 10.1099/jgv.0.001761 10.1016/j.psj.2022.102078 10.1093/nar/20.10.2517 10.3390/vaccines8020222 10.1093/nar/14.16.6551 10.1128/JVI.00188-09 10.3390/v12040451 10.1128/JVI.02049-09 10.1016/j.virol.2016.08.018 |
ContentType | Journal Article |
Copyright | 2024 Copyright © 2024. Published by Elsevier B.V. 2024 The Authors. Published by Elsevier B.V. 2024 |
Copyright_xml | – notice: 2024 – notice: Copyright © 2024. Published by Elsevier B.V. – notice: 2024 The Authors. Published by Elsevier B.V. 2024 |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1016/j.virusres.2024.199309 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1872-7492 |
ExternalDocumentID | oai_doaj_org_article_20c42b5747184ad5897f8619b6577a7b 10_1016_j_virusres_2024_199309 38181903 S0168170224000029 |
Genre | Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 0SF 123 1B1 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5RE 5VS 6I. 7-5 71M 8P~ 9JM AAAJQ AABNK AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXUO ABBQC ABFNM ABFRF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CJTIS CNWQP CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HMG HVGLF HZ~ IH2 IHE J1W KOM LCYCR LUGTX M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPM RPZ SCC SDF SDG SDP SES SEW SIN SPCBC SSH SSI SSZ T5K WH7 WUQ ZGI ~G- AAHBH AAXKI ADVLN AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c485t-86331320c426d64854020a60e9dea1b8cd73682ed72dca33bfc2591260a4df953 |
IEDL.DBID | RPM |
ISSN | 0168-1702 1872-7492 |
IngestDate | Tue Oct 22 15:06:01 EDT 2024 Tue Sep 17 21:30:47 EDT 2024 Sat Oct 26 01:51:58 EDT 2024 Thu Sep 26 15:47:23 EDT 2024 Sat Nov 02 12:30:09 EDT 2024 Sat Mar 02 16:00:43 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | UTR translation control Vectored vaccines Transgene expression Newcastle disease virus vector |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2024. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c485t-86331320c426d64854020a60e9dea1b8cd73682ed72dca33bfc2591260a4df953 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD 20993, USA. Retired. |
ORCID | 0000-0002-0892-1731 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10818242/ |
PMID | 38181903 |
PQID | 2919744587 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_20c42b5747184ad5897f8619b6577a7b pubmedcentral_primary_oai_pubmedcentral_nih_gov_10818242 proquest_miscellaneous_2919744587 crossref_primary_10_1016_j_virusres_2024_199309 pubmed_primary_38181903 elsevier_sciencedirect_doi_10_1016_j_virusres_2024_199309 |
PublicationCentury | 2000 |
PublicationDate | 2024-03-01 |
PublicationDateYYYYMMDD | 2024-03-01 |
PublicationDate_xml | – month: 03 year: 2024 text: 2024-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Virus research |
PublicationTitleAlternate | Virus Res |
PublicationYear | 2024 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Hu, Ni, Cao, Liu (bib0005) 2020; 8 Kim, Samal (bib0009) 2010; 84 Shao, Xie, Liang, Liu, Song, Feng, Zhang, Lin, Fu, Xie (bib0013) 2022; 101 Zhao, Zhang, Zsak, Yu (bib0018) 2015; 96 Kolakofsky (bib0010) 2016; 498 Elbehairy, Samal, Belov (bib0004) 2022; 103 Ikeda, Ligman, Warshamana (bib0006) 1992; 20 Viktorova, Khattar, Kouiavskaia, Laassri, Zagorodnyaya, Dragunsky, Samal, Chumakov, Belov (bib0015) 2018; 92 de Swart, Belov (bib0003) 2023; 62 Kozak (bib0011) 1986; 44 Bello, Yusoff, Ideris, Hair-Bejo, Jibril, Peeters, Omar (bib0002) 2020; 12 Ishida, Taira, Omata, Mizumoto, Hattori, Iwasaki, Kawakita (bib0007) 1986; 14 Alexander (bib0001) 2000; 19 Samuel, Subbiah, Shive, Collins, Samal (bib0012) 2011; 42 Shirvani, Varghese, Paldurai, Samal (bib0014) 2020; 10 Yan, Rout, Kim, Samal (bib0016) 2009; 83 Yu, Li, Dimitrov, Afonso, Spatz, Zsak (bib0017) 2020; 38 Jadhav, Zhao, Ledda, Liu, Ding, Nair, Ferretti (bib0008) 2020; 12 Yu (10.1016/j.virusres.2024.199309_bib0017) 2020; 38 Alexander (10.1016/j.virusres.2024.199309_bib0001) 2000; 19 Hu (10.1016/j.virusres.2024.199309_bib0005) 2020; 8 Elbehairy (10.1016/j.virusres.2024.199309_bib0004) 2022; 103 Samuel (10.1016/j.virusres.2024.199309_bib0012) 2011; 42 Kim (10.1016/j.virusres.2024.199309_bib0009) 2010; 84 Bello (10.1016/j.virusres.2024.199309_bib0002) 2020; 12 Ishida (10.1016/j.virusres.2024.199309_bib0007) 1986; 14 Ikeda (10.1016/j.virusres.2024.199309_bib0006) 1992; 20 de Swart (10.1016/j.virusres.2024.199309_bib0003) 2023; 62 Jadhav (10.1016/j.virusres.2024.199309_bib0008) 2020; 12 Shirvani (10.1016/j.virusres.2024.199309_bib0014) 2020; 10 Viktorova (10.1016/j.virusres.2024.199309_bib0015) 2018; 92 Kozak (10.1016/j.virusres.2024.199309_bib0011) 1986; 44 Shao (10.1016/j.virusres.2024.199309_bib0013) 2022; 101 Yan (10.1016/j.virusres.2024.199309_bib0016) 2009; 83 Zhao (10.1016/j.virusres.2024.199309_bib0018) 2015; 96 Kolakofsky (10.1016/j.virusres.2024.199309_bib0010) 2016; 498 |
References_xml | – volume: 12 start-page: 451 year: 2020 ident: bib0002 article-title: Exploring the prospects of engineered newcastle disease virus in modern vaccinology publication-title: Viruses Basel contributor: fullname: Omar – volume: 84 start-page: 2629 year: 2010 end-page: 2634 ident: bib0009 article-title: Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein publication-title: J. Virol. contributor: fullname: Samal – volume: 10 start-page: 2221 year: 2020 ident: bib0014 article-title: A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge publication-title: Sci. Rep. contributor: fullname: Samal – volume: 96 start-page: 40 year: 2015 end-page: 45 ident: bib0018 article-title: P and M gene junction is the optimal insertion site in newcastle disease virus vaccine vector for foreign gene expression publication-title: J. Gen. Virol. contributor: fullname: Yu – volume: 62 year: 2023 ident: bib0003 article-title: Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines publication-title: Curr. Opin. Virol. contributor: fullname: Belov – volume: 20 start-page: 2517 year: 1992 end-page: 2524 ident: bib0006 article-title: T7 promoter contacts essential for promoter activity publication-title: Nucleic Acids Res. contributor: fullname: Warshamana – volume: 14 start-page: 6551 year: 1986 end-page: 6564 ident: bib0007 article-title: Sequence of 2,617 nucleotides from the 3′ end of newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein publication-title: Nucleic Acids Res. contributor: fullname: Kawakita – volume: 8 start-page: 222 year: 2020 ident: bib0005 article-title: Newcastle disease virus as a vaccine vector for 20 years: a focus on maternally derived antibody interference publication-title: Vaccines Basel contributor: fullname: Liu – volume: 12 start-page: 1249 year: 2020 ident: bib0008 article-title: Patterns of RNA editing in newcastle disease virus infections publication-title: Viruses contributor: fullname: Ferretti – volume: 92 start-page: 00918 year: 2018 end-page: 00976 ident: bib0015 article-title: Newcastle disease virus-based vectored vaccine against poliomyelitis publication-title: J. Virol. contributor: fullname: Belov – volume: 42 start-page: 38 year: 2011 ident: bib0012 article-title: Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9 publication-title: Vet. Res. contributor: fullname: Samal – volume: 38 start-page: 925 year: 2020 end-page: 932 ident: bib0017 article-title: Genetic stability of a newcastle disease virus vectored infectious laryngotracheitis virus vaccine after serial passages in chicken embryos publication-title: Vaccine contributor: fullname: Zsak – volume: 44 start-page: 283 year: 1986 end-page: 292 ident: bib0011 article-title: Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes publication-title: Cell contributor: fullname: Kozak – volume: 103 year: 2022 ident: bib0004 article-title: Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability publication-title: J. Gen. Virol. contributor: fullname: Belov – volume: 101 year: 2022 ident: bib0013 article-title: Efficacy of recombinant Newcastle disease virus expressing HA protein of H9N2 Avian influenza virus in respiratory and intestinal tract publication-title: Poult. Sci. contributor: fullname: Xie – volume: 498 start-page: 94 year: 2016 end-page: 98 ident: bib0010 article-title: Paramyxovirus RNA synthesis, mRNA editing, and genome hexamer phase: a review publication-title: Virology contributor: fullname: Kolakofsky – volume: 19 start-page: 443 year: 2000 end-page: 462 ident: bib0001 article-title: Newcastle disease and other avian paramyxoviruses publication-title: Rev. Sci. Tech. contributor: fullname: Alexander – volume: 83 start-page: 5943 year: 2009 end-page: 5946 ident: bib0016 article-title: Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus publication-title: J. Virol. contributor: fullname: Samal – volume: 42 start-page: 38 issue: 1 year: 2011 ident: 10.1016/j.virusres.2024.199309_bib0012 article-title: Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9 publication-title: Vet. Res. doi: 10.1186/1297-9716-42-38 contributor: fullname: Samuel – volume: 62 year: 2023 ident: 10.1016/j.virusres.2024.199309_bib0003 article-title: Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2023.101348 contributor: fullname: de Swart – volume: 96 start-page: 40 issue: Pt 1 year: 2015 ident: 10.1016/j.virusres.2024.199309_bib0018 article-title: P and M gene junction is the optimal insertion site in newcastle disease virus vaccine vector for foreign gene expression publication-title: J. Gen. Virol. doi: 10.1099/vir.0.068437-0 contributor: fullname: Zhao – volume: 19 start-page: 443 issue: 2 year: 2000 ident: 10.1016/j.virusres.2024.199309_bib0001 article-title: Newcastle disease and other avian paramyxoviruses publication-title: Rev. Sci. Tech. doi: 10.20506/rst.19.2.1231 contributor: fullname: Alexander – volume: 12 start-page: 1249 issue: 11 year: 2020 ident: 10.1016/j.virusres.2024.199309_bib0008 article-title: Patterns of RNA editing in newcastle disease virus infections publication-title: Viruses doi: 10.3390/v12111249 contributor: fullname: Jadhav – volume: 44 start-page: 283 issue: 2 year: 1986 ident: 10.1016/j.virusres.2024.199309_bib0011 article-title: Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes publication-title: Cell doi: 10.1016/0092-8674(86)90762-2 contributor: fullname: Kozak – volume: 10 start-page: 2221 issue: 1 year: 2020 ident: 10.1016/j.virusres.2024.199309_bib0014 article-title: A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge publication-title: Sci. Rep. doi: 10.1038/s41598-020-59124-x contributor: fullname: Shirvani – volume: 92 start-page: 00918 issue: 17 year: 2018 ident: 10.1016/j.virusres.2024.199309_bib0015 article-title: Newcastle disease virus-based vectored vaccine against poliomyelitis publication-title: J. Virol. doi: 10.1128/JVI.00976-18 contributor: fullname: Viktorova – volume: 38 start-page: 925 issue: 4 year: 2020 ident: 10.1016/j.virusres.2024.199309_bib0017 article-title: Genetic stability of a newcastle disease virus vectored infectious laryngotracheitis virus vaccine after serial passages in chicken embryos publication-title: Vaccine doi: 10.1016/j.vaccine.2019.10.074 contributor: fullname: Yu – volume: 103 issue: 6 year: 2022 ident: 10.1016/j.virusres.2024.199309_bib0004 article-title: Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability publication-title: J. Gen. Virol. doi: 10.1099/jgv.0.001761 contributor: fullname: Elbehairy – volume: 101 issue: 12 year: 2022 ident: 10.1016/j.virusres.2024.199309_bib0013 article-title: Efficacy of recombinant Newcastle disease virus expressing HA protein of H9N2 Avian influenza virus in respiratory and intestinal tract publication-title: Poult. Sci. doi: 10.1016/j.psj.2022.102078 contributor: fullname: Shao – volume: 20 start-page: 2517 issue: 10 year: 1992 ident: 10.1016/j.virusres.2024.199309_bib0006 article-title: T7 promoter contacts essential for promoter activity in vivo publication-title: Nucleic Acids Res. doi: 10.1093/nar/20.10.2517 contributor: fullname: Ikeda – volume: 8 start-page: 222 issue: 2 year: 2020 ident: 10.1016/j.virusres.2024.199309_bib0005 article-title: Newcastle disease virus as a vaccine vector for 20 years: a focus on maternally derived antibody interference publication-title: Vaccines Basel doi: 10.3390/vaccines8020222 contributor: fullname: Hu – volume: 14 start-page: 6551 issue: 16 year: 1986 ident: 10.1016/j.virusres.2024.199309_bib0007 article-title: Sequence of 2,617 nucleotides from the 3′ end of newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein publication-title: Nucleic Acids Res. doi: 10.1093/nar/14.16.6551 contributor: fullname: Ishida – volume: 83 start-page: 5943 issue: 11 year: 2009 ident: 10.1016/j.virusres.2024.199309_bib0016 article-title: Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus publication-title: J. Virol. doi: 10.1128/JVI.00188-09 contributor: fullname: Yan – volume: 12 start-page: 451 issue: 4 year: 2020 ident: 10.1016/j.virusres.2024.199309_bib0002 article-title: Exploring the prospects of engineered newcastle disease virus in modern vaccinology publication-title: Viruses Basel doi: 10.3390/v12040451 contributor: fullname: Bello – volume: 84 start-page: 2629 issue: 5 year: 2010 ident: 10.1016/j.virusres.2024.199309_bib0009 article-title: Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein publication-title: J. Virol. doi: 10.1128/JVI.02049-09 contributor: fullname: Kim – volume: 498 start-page: 94 year: 2016 ident: 10.1016/j.virusres.2024.199309_bib0010 article-title: Paramyxovirus RNA synthesis, mRNA editing, and genome hexamer phase: a review publication-title: Virology doi: 10.1016/j.virol.2016.08.018 contributor: fullname: Kolakofsky |
SSID | ssj0006376 |
Score | 2.4500072 |
Snippet | •Cognate UTRs of NDV modulate the expression of transgene.•M UTRs strongly increase transgene expression in hela cells.•HN 5′UTR promotes efficient mRNA... Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector... • Cognate UTRs of NDV modulate the expression of transgene. • M UTRs strongly increase transgene expression in hela cells. • HN 5′UTR promotes efficient mRNA... |
SourceID | doaj pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 199309 |
SubjectTerms | Newcastle disease virus vector Transgene expression UTR translation control Vectored vaccines |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LSsQwFA0iCG7Et_VFBLdV2zy7VFFEcFYOuAtJ0-KIdEQ6oju_yU_yS7w3aWVGF27clTQtSe5Nc05zcy4hhwwgRQa3gJvUIuW81ingOJdmWpeofetYSDZxM5BXQ359J-6mUn1hTFiUB44DB-S85LkTyJ00t17oQtUaUL-TQimrXPj6nhQ9meq-wRLmzdR54Iejl9HzBNYcFOjOOR7RYxiCOLUUBcX-mRXpN-L8GTg5tRJdLpOlDkLS09j0FTJXNatkISaVfFsjmIqOxjANOq6p-Hz_oLbxlOEFkP20xeXpETCmp5iWAdyOjhva4lOvXVhsg09aGmqCh1UUT6FAwQDTjeDGMO02dmjoMX0J__7XyfDy4vb8Ku0SLKQl16JNtWSo3IgjLL2EIiSTVp5Uha9s5nTpFZM6r7zKfWkZc3UJbCkDCmS5rwvBNsg8tLvaIhSIjS8lau17xYvcWpjrytvSwVjVorYJOe7H2jxFHQ3TB5g9mN46Bq1jonUScoYm-a6NOtihALzDdN5h_vKOhBS9QU0HKSJUgFeN_mzAQe8BBuYcbqTYphpPoFKRAQ3jQquEbEaP-G4mIiAAWSwhesZXZvoxe6cZ3Qdd7wzlBQEybf9Hz3fIIvYlhsvtkvn2eVLtAX5q3X6YKl9ZexrU priority: 102 providerName: Directory of Open Access Journals – databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB6VrZC4oPIfKMhIXMM2azt2jm3VagGxF6jUm2XHCaSqkmqVreDGM_FIPAkzjrPawIEDt8Sxo4lnMj-a8TcAbzi6FBk-wtiklqkQtU7Rj3NppnVJ2LeOh2YTH1f58kK8v5SXe3A6noWhssqo-wedHrR1HJnH3ZzfNM38EzorhC4XqiApuXQH9kOSaAb7x-8-LFdbhZzz0GOO5qe0YOeg8NXb22a9QWNEyN0LQWf3ONUm7tioAOU_MVV_u6J_VlTumKjzA7gffUt2PJD_APaq9iHcHbpNfn8E1KOODfUbrKuZ_PXjJ7OtZ5wu2q5Ne7Jb1-h8ekb9GlAeWdeynlZ9i_WyLa20LMxE0asYHU_BgRX1IaGMMYsZHxa-mN2GpMBjuDg_-3y6TGPnhbQUWvapzjlBOh6VaL99jkMUZdr8qCp8ZTOnS694rheVVwtfWs5dXWIYlWFsZIWvC8mfwAzprp4Bw4jHlzmB8HslioW1qASUt6XDvaplbROYj3ttbgaADTNWnl2ZkTuGuGMG7iRwQizZziaA7DDQrb-YKCEm0O4khdxaWC91oWqNwaLLpVJWuQSKkaFmIm_4quafBLweJcDgz0gZFttW3QYnFRnGZ0JqlcDTQSK2ZJJrhN4XT0BPZGXyHdMnbfM1AH5nhDuIvtTz_yD6Bdyju6F87hBm_XpTvUR_qnev4v_yGzL_IT0 priority: 102 providerName: Elsevier |
Title | The effect of 5′ and 3′ non-translated regions on the expression of a transgene from a Newcastle disease virus vector |
URI | https://dx.doi.org/10.1016/j.virusres.2024.199309 https://www.ncbi.nlm.nih.gov/pubmed/38181903 https://www.proquest.com/docview/2919744587 https://pubmed.ncbi.nlm.nih.gov/PMC10818242 https://doaj.org/article/20c42b5747184ad5897f8619b6577a7b |
Volume | 341 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB5tFyFxQbwJj8hIXNM2tR07x2XFqoC24sBKe4v8SKCr3XRVpSu4IH4TP4lfwowTLwQOSNwqx67szOfOfPXnGYCXHEOKHB8hN2lkJkSjM4zjbJZr7Sj3reWh2MTxqlieiLen8nQPingXJoj2nV1P2_OLabv-FLSVlxduFnVis_fHhznlYUPfMpvABBEaOfrw-1vwUFIOYxnkR4r0O-kvVdfVertD30OJuheCrurxOSUOJb-FrpGPvFNI4j9yUn8HoX9qKX9zTkd34PYQVbKDfvZ3Ya9u78HNvs7kl_tA1elYr9xgm4bJH9--M9N6xukD8v-sI491jmGnZ1SpAZHINi3raNTnQSnb0kjDQk8EXc3oYgo2rKgCCZ0Vs-Gsh4XFs6twHPAATo5efzhcZkPNhcwJLbtMF5ySOc4dem5fYBPxS1PM69LXJrfaecULvai9WnhnOLeNQwKVIysywjel5A9hH-ddPwaGXMe7gtLveyXKhTG4_ZU3zuK7amRjEpjFd11d9qk1qqg5O6uioSoyVNUbKoFXZJLr3pQaOzRsth-rASBVmLuVRLa1MF7qUjUaaaItpFJG2QTKaNBqiDL66AG_av3PCbyICKhwG9LZimnrzQ47lTkyMyG1SuBRj4jraUZwJaBHWBmtY_wEkR9SfUekP_n_oU_hFq2g1809g_1uu6ufYyDV2RQm0695CjcO3rxbrtLwd0Qa9tJPxQQiMg |
link.rule.ids | 230,315,730,783,787,867,888,2109,4511,24130,27938,27939,45599,45693,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RUFUuqO-m9OFKvaZL1nbsHCkqWgrspSBxs-w4oUFVglZZRG_9Tf1J_BJmnGS1aQ899Bb5EU08k5lvNOMZgI8cIUWCU-iblDIWotQx4jgXJ1rnVPvW8dBs4nSezs7F1wt5sQEHw10YSqvsdX-n04O27kcm_WlOrqtq8g3BClWXC1mQFFx6AFuIBjIU9q39o-PZfKWQUx56zNH6mDasXRS--nRTLZZojKhy91TQ3T1OuYlrNiqU8h-Zqr-h6J8ZlWsm6vAx7PTYku135D-BjaJ-Cg-7bpM_nwH1qGNd_gZrSibvfv1mtvaM00Pd1HFLdusHgk_PqF8DyiNratbSrts-X7amnZaFlSh6BaPrKTgwpz4kFDFmfcSHhS9mNyEo8BzOD7-cHczivvNCnAst21innEo67uVov32KQ-Rl2nSvyHxhE6dzr3iqp4VXU59bzl2ZoxuVoG9khS8zyV_AJtJdvAKGHo_PUyrC75XIptaiElDe5g7PqpSljWAynLW57gpsmCHz7MoM3DHEHdNxJ4LPxJLVaiqQHQaaxaXpJcQE2p0kl1sL66XOVKnRWXSpVMoqF0E2MNSM5A1fVf2TgA-DBBj8GSnCYuuiWeKiLEH_TEitInjZScSKTIJGiL54BHokK6PvGM_U1fdQ8DuhuoOIpV7_B9Hv4dHs7PTEnBzNj3dhm2a6VLo3sNkulsVbxFate9f_O_cZsyQ4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWgCNQNb0p4FCOxzcxkHMfOEgqj8uioCypVYmH5kZSB1hkNmQpY8U18El_CvU5cSFkgdTdy7JEdn-SeK5-cS8gzBpQig0uQm9Q8zfNapsDjTJpJadH71rBQbGJvXuwe5G8O-WGvqvzSyyq9NYuRPz4Z-cXHoK1cnthx1ImN9_d2MvRhg9gyXrp6fJlcgYd2ImOm3r-FCxYKywGjgSxJoIpn-4-263SxWkMEQrvuaY4f7LEJ2odi9IIAyQYxKlj5D0LVv1T0vKLyrxA1u0E-xMV1ypTPo3VrRvb7Od_Hi63-JrneM1f6vOtzi1yq_G1ytatl-e0OwQp4tFOH0Kam_NePn1R7Rxn-8I1PW4yKx0BtHcVqEIB22nja4qivvRrX40hNQ08AdkXx4xdomGOVEzyPpv15Eg23lp6GI4e75GD26v3ObtrXdUhtLnmbyoKhYeTEAjtwBTRhDquLSVW6SmdGWidYIaeVE1NnNWOmtpCkZZB56dzVJWf3yAbMu7pPKORTzhZo8e9EXk61hleMcNoa2Ima1zoh47iTatnZd6ioa_ukIgwUwkB1MEjIC9zws95ovx0amtWR6rdBhbkbjgm9zLXjshS1hFTUFFwILUxCyggX1TOZjqHAXy3-O4GnEV8KHnU8v9G-atbQqcwg-8u5FAnZ6vB2Ns0I3YTIARIH6xheAXwFO_GIpwcXH_qEXNt_OVPvXs_fPiSbuJhOpveIbLSrdfUYeFtrtsMD-hvLnENU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+5%E2%80%B2+and+3%E2%80%B2+non-translated+regions+on+the+expression+of+a+transgene+from+a+Newcastle+disease+virus+vector&rft.jtitle=Virus+research&rft.au=Chowdhury%2C+Ishita+Roy&rft.au=Viktorova%2C+Ekaterina&rft.au=Samal%2C+Siba+K.&rft.au=Belov%2C+George+A.&rft.date=2024-03-01&rft.pub=Elsevier+B.V&rft.issn=0168-1702&rft.eissn=1872-7492&rft.volume=341&rft_id=info:doi/10.1016%2Fj.virusres.2024.199309&rft.externalDocID=S0168170224000029 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-1702&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-1702&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-1702&client=summon |